See More StocksHome

LXRX

Lexicon Pharmaceuticals Inc

Show Trading View Graph

Mentions (24Hr)

0

-100.00% Today

Reddit Posts

r/pennystocksSee Post

Anyone else picking up LXRX?

r/pennystocksSee Post

Insiders Buying Millions & Millions of Dollars Worth of Stock Trading & Ownership - Lexicon Pharmaceuticals, Inc. * LXRX *

r/pennystocksSee Post

} LXRX { Lexicon Pharmaceuticals, Inc. Insiders Are Buying Buying Millions & Millions of Dollars Worth of Shares. Tremendous Opportunity to Triple Your Money.. Check it out..,,

r/pennystocksSee Post

( LXRX ) Lexicon Pharmaceuticals, Inc Check It Out

r/pennystocksSee Post

October's top penny stocks to watch, per insiders

r/pennystocksSee Post

Lexicon pharmaceuticals is coming

r/pennystocksSee Post

Lexicon Pharmaceuticals director just picked up 1,000,000 shares

r/pennystocksSee Post

I might have what could be both the worst/best investment you can get for the next few months.

r/wallstreetbetsSee Post

LXRX ?

r/stocksSee Post

Lexicon pharmaceuticals $LXRX

r/pennystocksSee Post

Lexicon Pharmaceuticals CEO Lonnel Coats Executes Purchase of 40,000 Shares of Common Stock Shares Rise Premarket

r/pennystocksSee Post

Over $72M bet on these Biotechnology and Fintech Stock? Check out these penny stocks insiders are aggressively buying.

r/pennystocksSee Post

June's penny stock marvels: supercharge your portfolio with these gems!

r/pennystocksSee Post

Take a look at C4 Therapeutics CCCC

r/StockMarketSee Post

LXRX

r/stocksSee Post

LXRX - 18$ Price Target

r/optionsSee Post

LXRX 18$ price target!

r/optionsSee Post

Opinions on LXRX

r/ShortsqueezeSee Post

NES & LXRX On The Move Now

r/wallstreetbetsSee Post

$LXRX Lexicon pharmaceuticals imminent catalyst JP Morgan Health Conference with NDA

r/wallstreetbetsSee Post

LXRX - Stock doubled when it got its UK approval for diabetes med - on track to be approved in US soon

r/wallstreetbetsSee Post

LXRX🚀🚀🚀✈️✈️✈️

r/wallstreetbetsSee Post

LXRX🚀🚀🚀

r/wallstreetbetsSee Post

LXRX 🚀🚀🚀

r/wallstreetbetsSee Post

LXRX 🚀🚀🚀

Mentions

LXRX thank me later 👋

Mentions:#LXRX

What are your thoughts on LXRX? I hope we get some news this week from the conference. You think they are setting up for a buyout? They have been very quiet so I think something is brewing.

Mentions:#LXRX

Please join our subreddit for LXRX lots of good people in there

Mentions:#LXRX

I’ve had huge returns on AEVA(300%), LASR(100%), and ARBE(70%). LAZR was a bust but I got out just about even (the stock that taught me a lot of the above points). Waiting for LXRX to turn a bigger profit. Watching XENE and a whole bunch of Quantum computing stocks right now.

I’ve had huge returns on AEVA(300%), LASR(100%), and ARBE(70%). LAZR was a bust but I got out just about even(the stock that taught me a lot of the above points). Waiting for LXRX to turn a bigger profit. Watching XENE and a whole bunch of Quantum computing stocks right now.

A possible takeover bid for Lexicon Pharmaceuticals (LXRX) could be reasonable and legal if certain structural, strategic and financial factors exist that justify a buyer (such as Novo Nordisk or another pharmaceutical company) seeing sense in acquiring it. Below I detail the logical, legal and financial reasons that could support this hypothesis: 🧠 LEGAL AND STRATEGIC REASONING OF A POSSIBLE TAKEOVER OF LEXICON 1. ✅ Legality: is a takeover bid viable? Yes, legally any public company can be the subject of a takeover bid if: The buyer offers an attractive premium over the market price. Report to the SEC (in the US) using the Schedule TO form. Meets transparency and fairness requirements (SEC Rule 14d). The approval of the Board of Directors is obtained (if it is a friendly takeover bid) or pressure is applied with a hostile takeover bid if there is resistance. 👉 LXRX does not have public antitakeover clauses or structures with dual voting shares (like Alphabet or Meta), so it is legally vulnerable to a takeover. 2. 🎯 Strategic reasons for a takeover bid A. Undervalued valuable assets LXRX has approved drugs (such as Inpefa) and others in clinical phases, with high potential value in the medium term. The agreement with Novo Nordisk already demonstrates third-party interest in its assets (e.g. LX9851). Its current capitalization (~$250 M) is much lower than the value that its products could generate if they entered the global market. B. Savings in marketing costs A buyer with a global commercial structure (such as Novo or AstraZeneca) could scale Inpefa without duplicating costs, accelerating profits and profitability. C. Synergies Integrating LXRX would allow us to take advantage of clinical data, patents, scientific personnel and development pipelines without starting from scratch. 3. 💰 Financial reasons for a takeover bid A. Affordable purchase price With a market cap of ~$250 M, a takeover bid of $500–600 M ($2–2.50 per share) would be feasible and attractive.

Mentions:#LXRX#LX

Listen $LXRX

Mentions:#LXRX

I know this is a big money group not a penny stock group hopefully it doesnt get me banned. Just wanted to throw this out. Im watching closely this biopharma penny stock $LXRX. Trading at 70¢ as we speak. The company has one drug approved waiting for a second one (which both drugs are going to be for heart failure) the one we are waiting is on its 3rd phase. But They recently got a 75 million deal from Novo Norsdisk the creator of ozempic to create another weightloss drug. Analyst think this stock can go up to 6$ a share. Just wanted to share this for you to do your research. This is not financial advise

Mentions:#LXRX

That’s one of my biggest holdings. LXRX. Check out our new subreddit. Some really smart people in there!

Mentions:#LXRX

Exton and Granowitz, MD have made it clear they are looking to partner. Artal knows LXRX cannot launch in HCM or pain as evidenced by the sota launch failure. Is it a partnership or acquisition and I thought Pfizer best suited over AZ or Lilly. However, Vertex needs LX9211 for chronic pain. VX-548 is not the answer … no fast track from the fda like lx9211.

GERN ALBA LXRX trust

Mentions:#GERN#LXRX

LXRX slowly but surely getting back to my initial buy price. Keep going, I'm tired of holding this bag! 

Mentions:#LXRX

No idea I'm in LXRX and KULR though

Mentions:#LXRX#KULR

Ya if not for LXRX would been rough

Mentions:#LXRX

LXRX waking up

Mentions:#LXRX

I thought the same thing. Also I'm very shocked that LXRX is not listed on here. That stock has the most potential of any of these.

Mentions:#LXRX

I'm in IXHL and LXRX because they are both undervalued atm

Mentions:#IXHL#LXRX

LXRX should make a run soon

Mentions:#LXRX

I don’t see LXRX or ARBE. Made a lot of money on the latter; expect to do so on the former within the next few weeks. Did really well with AEVA(5X) too but I don’t know if that qualifies.

ACET is my medium term move, and watching LXRX for a good entry but a little hesitant

Mentions:#ACET#LXRX

Haven’t traded LXRX but it’s on my watch list and it’s getting some movement

Mentions:#LXRX

Big fan KRKNF.. I would go KRKNF, GRYP, and MVIS.. LXRX or like you mentioned RXRX(leaps)

You want the honest winning call here? LXRX leaps NFA

Mentions:#LXRX

What's going on with LXRX? They beat earnings, but sinking

Mentions:#LXRX

LXRX, CISO, NVNI, SRXH, PAPL, IBIO. NEGG is my only long play just because it's a comfort stock lol  

what do you think about LXRX?

Mentions:#LXRX

LXRX kinda disappointing

Mentions:#LXRX

LXRX pumping towards earnings?

Mentions:#LXRX

Smells like LXRX

Mentions:#LXRX

LXRX earnings come out today. Should be good with 75 million they received from Nova Nordisk.

Mentions:#LXRX

Sorry I was replying to what someone had said about me posting earlier about LXRX having an earnings report/call tomorrow would that send the stock up. They said there maybe some news about a merger or buyout in play also.

Mentions:#LXRX

Any thoughts on LXRX tomorrow or the next day. They have earnings report tomorrow afternoon. I would think it would be good with the 75 million upfront money they got from Nova Nordisk and access to up to 1 billion dollars from them for their weight lose drug. It’s been running fairly low the last few weeks. ER may give it a bump up.

Mentions:#LXRX

LXRX Monday is the day to buy in.

Mentions:#LXRX

LXRX is a favorite of mine at the moment. Solid company with some big catalysts coming, trading at an affordable price. Float is kinda big though

Mentions:#LXRX

So you thinking we get 3 green days next week? I want to liquidate my entire position in WOLF after earnings tonight and throw it all into LXRX before 8pm tonight or possibly premarket on Monday.

Mentions:#WOLF#LXRX

Im big on LXRX and the new subreddit is a great community.

Mentions:#LXRX

I’m also in since about .45 and I’ll probably sell in the $1-$2 range depending on how momentum looks when it breaks through. Then wait for a dip to buy back and hold long, I think LXRX has a pretty solid chance of a buyout that could send the price to somewhere around the $7-$12 range.

Mentions:#LXRX

If you’re referring to LXRX post in r/LXRXstock

Mentions:#LXRX

In LXRX, WOLF. No real action yet. Missed out on KIDZ

Mentions:#LXRX#WOLF

$LXRX is a good one, for sure. Should check out $SLS if you like small cap bios with huge upside.

Mentions:#LXRX#SLS

I've been picking up LXRX for awhile 8k shares @.58

Mentions:#LXRX

LXRX Earnings report is Tomorrow financials are off the charts what does everyone think

Mentions:#LXRX

Your post with title "LXRX Earnings report i Tomorrow" has been removed from r/pennystocks because it is too short. Posts must have at least 50 characters to ensure meaningful discussions. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*

Mentions:#LXRX

I have acquired 250,000 shares of LXRX. Thank you for the tip!

Mentions:#LXRX

Can’t see premarket data for LXRX and apparently earnings are today 🤔

Mentions:#LXRX

But I’ll check out LXRX

Mentions:#LXRX

2000 shares @ 0.50. Bought more LXRX.

Mentions:#LXRX

I’m way long on LXRX. Way under-valued. Just signed a big deal with Novo Nordisk “up to $1 billion” but received $45 million upfront. I always had a “no” bio stocks policy because they are always “close to FDA” approval (which never comes) but this one already had an approved drug and many more in the pipeline. Great balance sheet and are setting themselves up for a buyout (see the excellent post in this group on LXRX from last week). Please join our subreddit. Really great community we started.

Mentions:#LXRX

It’s a long term play. I was holding and it was going down so I jumped on the LXRX train and got my money back and doubled it. I’d consider getting back into GORO as it seems to have hit a low and I liked the company.

Mentions:#LXRX#GORO

I’ll have to look into LXRX then especially with their earnings in 3 days, have you heard of ABEO or CGON?? Those are the medical stocks i have been looking at even though they’re not penny stocks per se CGON spiked from $22 closing Friday to a high of $32!

„Lexicon Pharmaceuticals ($LXRX) has already received FDA approval for Inpefa (sotagliflozin) for heart failure, and has initiated commercial rollout alongside Viatris.“ Not correct: It’s only for markets outside U.S. and Europe - not for U.S., why that?

Mentions:#LXRX

Damn, this $LXRX setup is juicy with all those catalysts coming! Their pipeline is looking solid with LX9211 Phase 2b DPNP data coming Q1 2025 and the ongoing Phase 3 SONATA HCM study. That $25M upfront with potential for $197M in additional milestones is massive for a company trading at these levels. And they've already got an FDA-approved product with INPEFA actually generating revenue - rare for sub-$1 biotechs. Thanks for sharing the chart - will definitely be watching this one closely alongside my core positions. Could be a great end-of-year runner! May use it as a play while I wait for the next leg of $AITX

Way under valued. Just signed a big deal with Novo Nordisk “up to $1 billion” but has $45 million upfront. I always had a “no” bio stocks policy because they are always “close to FDA” approval(which never comes) but this one already had an approved drug and many near approval. Great balance sheet and are setting themselves up for a buyout (see the excellent post in this group on LXRX from last week). Please join our subreddit. Really great community we started.

Mentions:#LXRX

I’m liking $WOLF and $WW but even then $INTJ and $LXRX look like good plays. $BYD is a good long term hold though for sure.

Any updates on this? I like $WOLF and $WW but also even $LXRX and $INTJ promising too…?

I was told the play is $WOLF and $WW, also heard $INTJ and $LXRX though, what’s everyone’s thoughts? I’m currently liking $WOLF and $WW

why LXRX?

Mentions:#LXRX

I was in GORO but moved my money into LXRX and that was definitely a good move. I thought GORO had a solid earnings report. Price has dipped since. Hopefully it can recover. Keeping profitable is a challenge for them but sounds like they have enough money to continue operating for a fair amount of time.

Mentions:#GORO#LXRX

In on $LXRX, lets go!!!

Mentions:#LXRX

LXRX as well

Mentions:#LXRX

LXRX looks decent - got FDA approval already and Novo partnership could be huge if obesity drug hits. Metabolic/heart market is printing cash right now. $AITX still my favorite penny though - been loading under a penny while these Fortune 50s keep signing contracts. Both are overlooked but AITX has way more short-term catalysts dropping every week.

Mentions:#LXRX#AITX

Did someone say the ship has sailed? 🤣Whoever said that does not know how stocks work. Especially a stock with the spread like LXRX. I'm holding, and you should to my dude! Good post

Mentions:#LXRX

Debbane is definitely an interesting aspect of it, and even with more background on him and his typical investment style, I doubt one can accurately predict his next moves in LXRX. My guess of a M&A being in the works is based off of looking at the company, how it is acting, and how it is positioned and then trying to come up with a hypothesis that explains that behavior. Then we test that hypothesis and see if it is right or not. Knowing Debbane is chairman of the BOD, and with him included Invus/Artal hold 3/8 positions on the board, leads me to believe that anything major that the company has done, including all of the restructuring and hiring of execs has had their approval up to this point. Example being that Exton's offer letter was written personally by Debbane. Which is to say, if they are preparing for an M&A, then Invus/Artal have been supportive of it from the beginning. If no M&A is in the works, and my hypothesis is dog shit, then Lexicon's repositioning still had to have had the Board's approval, and Invus/artal will have the finally say in any major changes to the company

Mentions:#LXRX

Lower float than LXRX. But you’re definitely right. This need serious institutional investment to move significantly

Mentions:#LXRX

LXRX!!!!

Mentions:#LXRX

LXRX isn’t a meme stock.

Mentions:#LXRX

I’m in both ! Heavy in LXRX

Mentions:#LXRX

LXRX is the play

Mentions:#LXRX

I am in LXRX but not for SS, I am gambling on rumors of potential buyout. 

Mentions:#LXRX

Been holding LXRX longer than I have held anything in the penny stock world. But this year looks much better and brighter for me. Finally 😅

Mentions:#LXRX

I’m starting a rumor ! LXRX is getting bought out ! They used the 45 million to pay off all debts

Mentions:#LXRX

Can’t believe that no one is talking about LXRX! 5th day green and climbing

Mentions:#LXRX

There’s a 25 year LXRX price history on a website called Macrotrends if anyone else finds dates for major purchases of LXRX made by the largest shareholders and wants to share (to give us an idea of a ballpark buyout).

Mentions:#LXRX

This is a great summary. In my opinion, AstraZeneca would be the best company to offer a buyout to gain exclusive rights to INPEFA since their SLG2 inhibitor lost its exclusive license in February, and now a generic is available. (However, AstaZeneca licensed the generic, so they get a cut, but their SLG2, Farxiga, generated a large portion of revenue for the company.) AstraZ could market LXRX’s SLG2, INPEFA, as superior to Jardiance in reducing cardiac events and stroke to corner the market. Whatever the scenario, it would be great to see a buy-out of $8-$12 per share, but the big shareholders might want more since they bought the stock back when it was in the double digits.

Mentions:#SLG#LXRX

Dude LXRX clearly was meant to be held long lol. My paper hands couldn’t do it lmao. I bought it with my swing/ day trade funds lol

Mentions:#LXRX

LXRX is going to break out. HIND is only merging the company for a fast way to gain access to Nasdaq. They dont want most of the assets

Mentions:#LXRX

Finally out of LXRX with a little profit. But happy to be out. held that for too long lol

Mentions:#LXRX

Been waiting a good month for LXRX to come back up, a lovely green day.

Mentions:#LXRX

Are you in LXRX?

Mentions:#LXRX

LXRX has to break clean over like .71

Mentions:#LXRX

How you doing on LXRX? We have to bust through .70

Mentions:#LXRX

LXRX come on do your thing. I want out of you already. get to .70 lmao

Mentions:#LXRX

OK so I was not around for that (had to look it up to get the story). But based on the limited initial research I did these are two completely different companies. LXRX has a large cash position and very high institutional ownership. It just signed a big deal with Novo Nordisk “up to” $1 billion with $45 million up front. I used to have a “no bio company stock” rule as they are always an FDA approval away from taking off and those never seem to come. One of the reasons I bought in is because they not only have FDA approved working products but they are increasing their R&D and seem to be setting themselves up for being bought out. I think they are very under valued. I might be right or wrong but I like how it’s aligning.

Mentions:#LXRX

You guys holding LXRX? Seeing talks about potential rs announcement

Mentions:#LXRX

I wish I had the patience sometimes but I'm learning and I'm adapting , I had 1200 shares of LXRX when the buzz happened at 0.49 and it went south so I sold. Realising your strategy is impatient is one that stings but at least its learned for the future.

Mentions:#LXRX

More LXRX calls and MVIS leaps because 🚀

Mentions:#LXRX#MVIS

If you’re new here just trust me dude, part of why LXRX is not pumping is the float is giant and the RS is looming overhead. Scalp or it or flip it or whatever but don’t long hold

Mentions:#LXRX#RS

Okay I got downvoted for the LXRX thing but I told yall a RS has to come lol. And when they announce it and the price tanks I don’t wanna see anyone in here complaining lol

Mentions:#LXRX#RS

Has anybody else read the SEC filings on LXRX's website? It talks about a vote for doing an RS split and common stock issuance but I'm not smart enough to deduce if what they talk about is positive.

Mentions:#LXRX#RS

FU short sellers of LXRX ! Only you would sell or manipulate at .62 Mafaka

Mentions:#LXRX

LXRX news

Mentions:#LXRX

LXRX back in the .6 range nice dude

Mentions:#LXRX

Need all the help with LXRX ! I’m in heavy ! Shorted like a submarine , I don’t call out many ! Yet we could really use some retail support

Mentions:#LXRX

If you want certainty this week: LXRX, SES AI, PEPG

LXRX is going to break out. Reports are the latest info on their obesity drug is positive. Volume is rampning up. I own 75 call options on this one for Hanuary 26 and January 27

Mentions:#LXRX

LXRX.....gonna break out next this week or next.

Mentions:#LXRX

I saw that too, I’m hoping to fully jump from RSLS over to LXRX before earnings.

Mentions:#RSLS#LXRX

LXRX trying to break out, I think news is coming there too

Mentions:#LXRX